Altogether, the data demonstrate that the JNK/c-Jun pathway contributes to the promotion of ULBP2 expression in breast cancer cells and, to a certain extent, is involved in the mechanism by which miR-17-5p modulates ULBP2. Here, MAPK8 is linked to breast carcinoma.